Disclosure: This site earns commissions from affiliate links (Amazon, Etsy, and others) at no extra cost to you.   Full affiliate disclosure →

Updated July 2026 · 8 min read

This article was created with AI assistance.

Myasthenic Crisis: The ICU Nurse's Guide

⚕️ Medical Disclaimer: This content is for educational purposes only and is intended for licensed healthcare professionals. It does not constitute medical advice and should not replace clinical judgment, facility protocols, or physician orders. Always verify medications, doses, and procedures with your institution's guidelines.

Part of the ICU Emergencies Hub — browse every related guide in one place.

Myasthenic crisis is one of the few neuromuscular emergencies where the patient can be talking to you, looking comfortable, and be an hour away from a respiratory arrest. The muscles fail quietly. Your job at the bedside is to catch the failing bellows before the gas exchange tells you — because by the time the oxygen saturation drops, you are already late.

The short version: Myasthenia gravis is an autoimmune attack on the acetylcholine receptors at the neuromuscular junction. A myasthenic crisis is when weakness spreads to the breathing muscles badly enough to need ventilatory support. The danger is ventilatory (bellows) failure, not lung disease — so you trust bedside mechanics (NIF, vital capacity), swallow, and secretions more than the pulse oximeter, and you protect the airway before the blood gas falls apart.

Why the breathing fails

In myasthenia gravis, antibodies block and destroy the acetylcholine receptors on the muscle side of the neuromuscular junction. The nerve still fires and still releases acetylcholine, but fewer receptors are there to catch it, so the muscle contracts weakly. The hallmark is fatigable weakness: the muscle works at first and then fades with repetition. That is why classic myasthenia shows drooping eyelids and double vision that worsen through the day, and why a patient can lift their head fine once but not hold it up.

A crisis happens when that fatigable weakness reaches the diaphragm and the accessory and bulbar muscles. The diaphragm tires, tidal volumes shrink, the patient breathes faster and shallower to compensate, and CO2 starts to climb. Meanwhile the bulbar muscles that protect the airway — swallow, cough, tongue — weaken too, so secretions pool and aspiration risk climbs. It is a pump problem and an airway-protection problem at the same time.

What tips a patient into crisis

Crises are often triggered. The common precipitants are infection (especially respiratory), aspiration, surgery and the stress around it, tapering or missing the usual immune/cholinesterase medications, pregnancy, and — very importantly for the ICU — new drugs that block the junction further. Knowing the trigger matters because treating it (for example, the underlying pneumonia) is part of resolving the crisis.

The drug list that makes myasthenia worse. Several common ICU drugs impair neuromuscular transmission and can unmask or deepen a crisis: aminoglycosides and fluoroquinolones and macrolides, magnesium (IV magnesium can precipitate frank respiratory failure — a huge trap during an eclampsia or repletion order), beta-blockers and some calcium-channel blockers, and neuromuscular blockers, to which these patients are unpredictably sensitive. Before you hang anything on a myasthenic patient, it is worth a second look. See our note on IV magnesium replacement.

The monitoring that actually matters: NIF and vital capacity

This is the core bedside skill. Pulse oximetry and even the blood gas are late in bellows failure — a patient can maintain a normal saturation on a rising respiratory rate right up until they crash. What tracks the failing pump earlier is mechanics:

The trend across serial measurements matters far more than any single number. A patient whose vital capacity was fine four hours ago and is dropping now is telling you the crisis is progressing, even if they still look okay.

Bedside tell — the "20/30/40 rule" as a memory aid, not a mandate: a vital capacity falling toward ~20 mL/kg, a NIF weaker than about -30 cmH2O, and a maximal expiratory pressure under ~40 cmH2O together describe a patient sliding toward needing support. Also watch the human signs: single-breath counting getting shorter, a weak wet cough, staccato speech, the head dropping, and — the ominous one — a patient too tired to keep working who suddenly looks calm. Rising CO2 and the classic paradoxical belly-in-on-inspiration are late.

Myasthenic crisis vs. cholinergic crisis

Here is the distinction that trips people up. Patients on cholinesterase inhibitors (like pyridostigmine) are getting more acetylcholine at the junction on purpose. Too little medication leaves them weak — a myasthenic picture. But too much cholinesterase inhibitor causes a cholinergic crisis, which also causes weakness, plus a flood of muscarinic effects. Both crises can cause respiratory failure, so you cannot separate them on weakness alone.

FeatureMyasthenic crisisCholinergic crisis
Underlying problemToo little effective acetylcholine effect (undertreated / triggered)Too much cholinesterase inhibitor
PupilsNormal or largeSmall (miosis)
SecretionsNot excessive from the drugExcessive — SLUDGE: salivation, lacrimation, urination, defecation, GI upset, emesis
Other muscarinic signsAbsentBradycardia, bronchospasm, sweating, fasciculations, cramps
Core dangerRespiratory failureRespiratory failure + secretions

In practice, when respiratory failure is imminent the safest move is the same regardless of which crisis it is: secure the airway and support ventilation, hold the cholinesterase inhibitor (it adds secretions and muddies the picture on the vent), and let the team sort out the cause. The extra cholinergic signs — tiny pupils and pouring secretions — are your clue that overdose, not undertreatment, is driving it.

How a crisis is treated

The airway and ventilation come first — sometimes a trial of non-invasive support in a cooperative patient with a protected airway, but a low threshold to intubate once the mechanics are failing or secretions are unmanageable. The definitive treatments target the antibodies: plasma exchange (plasmapheresis) or IVIG, usually alongside corticosteroids for the longer game. Steroids can transiently worsen weakness in the first days, which is one reason these patients are watched closely in an ICU. The trigger — infection, aspiration, an offending drug — is hunted down and fixed in parallel.

What the bedside nurse owns

You own the early detection. That means serial NIF and vital capacity on the schedule the team sets, a hard look at swallow and secretions, single-breath counting as a quick trend tool, and a running audit of every new medication against the myasthenia danger list. It means positioning to protect the airway, aggressive pulmonary hygiene, and speaking up early — the whole point is to convert an emergent middle-of-the-night crash intubation into a controlled, planned one. And it means watching the intubated crisis patient for the steroid dip and for the secretions that signal a cholinergic overshoot.

Bottom line

Myasthenic crisis is fatigable weakness that has reached the breathing and swallowing muscles — a ventilatory pump and airway-protection failure, not a lung disease. Trust bedside mechanics (NIF, vital capacity, single-breath count) over the pulse oximeter, know the drug list (aminoglycosides, magnesium, and friends) that deepens it, and separate it from cholinergic crisis by the pupils and secretions. Intervene on the trend, not the crash — the win is a planned airway, and it belongs to the nurse who was watching the numbers fall.

This article is general educational information for licensed clinicians and students, not medical advice or a substitute for your institution's protocols, pharmacy guidance, or a provider's orders. Always follow facility policy and verify doses independently.

Get the ICU Notebook

Free investing strategies built for nurses. One email per week, no fluff.

Yes, send it free

No spam. Unsubscribe any time.